Polarean Imaging (POLX) Competitors

Novacyt (LON:NCYT) and Polarean Imaging (LON:POLX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability.

Do insiders & institutionals believe in NCYT or POLX?

10.7% of Novacyt shares are held by institutional investors. Comparatively, 10.2% of Polarean Imaging shares are held by institutional investors. 0.5% of Novacyt shares are held by company insiders. Comparatively, 3.5% of Polarean Imaging shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Which has more volatility and risk, NCYT or POLX?

Novacyt has a beta of -1.86, suggesting that its share price is 286% less volatile than the S&P 500. Comparatively, Polarean Imaging has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500.

Is NCYT or POLX more profitable?

Novacyt has a net margin of -203.06% compared to Polarean Imaging's net margin of -1,333.97%. Novacyt's return on equity of -47.73% beat Polarean Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Novacyt	-203.06%	-47.73%	-27.98%
Polarean Imaging	-1,333.97%	-86.11%	-32.28%

Does the media prefer NCYT or POLX?

In the previous week, Novacyt had 1 more articles in the media than Polarean Imaging. MarketBeat recorded 1 mentions for Novacyt and 0 mentions for Polarean Imaging. Novacyt's average media sentiment score of 0.58 beat Polarean Imaging's score of 0.00 indicating that Novacyt is being referred to more favorably in the media.

Company	Overall Sentiment
Novacyt	Positive
Polarean Imaging	Neutral

Which has higher earnings and valuation, NCYT or POLX?

Novacyt has higher revenue and earnings than Polarean Imaging. Novacyt is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Novacyt	£19.63M	1.45	-£36.80M	-£0.59	-68.47
Polarean Imaging	£3.09M	2.52	-£69.44M	-£0.01	-58.64

Summary

Novacyt beats Polarean Imaging on 8 of the 13 factors compared between the two stocks.